Efficacy of FP-025: A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma
- Allergy. 2023 Feb;78(2):559-562. doi: 10.1111/all.15513.
Affiliations
- 1. Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Center (Location AMC), Amsterdam, The Netherlands.
- 2. Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
- 3. Department of Respiratory Medicine and Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden.
- 4. Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
- 5. Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.
- 6. Department of Pathology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Center (Location AMC), Amsterdam, The Netherlands.
- 7. Department of Pulmonary Medicine, Amsterdam University Medical Center (Location AMC), Amsterdam, The Netherlands.
PMID: 36094742
DOI: 10.1111/all.15513
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: MMPResearch Areas: Inflammation/Immunology